Patents
Patents for A61K 45 - Medicinal preparations containing active ingredients not provided for in groups (115,020)
03/1990
03/07/1990EP0357332A2 Renin inhibitors useful for the treatment of aids by inhibition of HIV protease
03/07/1990EP0357030A2 Use of thromboxane A2 receptor antagonists for the preparation of a pharmaceutical composition for treating skin injuries
03/07/1990CN1040202A Process for preparing dna polyanion platinum (ii) derivatives
03/06/1990US4906638 Dextromethorphan potentiator for anticonvulsant composition and method
03/06/1990US4906625 Analgesic and anti-inflammatory compositions comprising diphenhydramine and metyhods of using same
03/06/1990US4906613 Antiglaucoma compositions and methods
02/1990
02/28/1990EP0355279A2 Use of nitrogen-containing compounds as antiparasitics, and compositions containing them
02/28/1990EP0355245A1 Use of retrovirus reverse transcriptase inhibiting agents
02/28/1990EP0355131A1 Acyl deoxyribonucleoside derivatives and uses thereof
02/27/1990US4904479 Collidal particles coated with hydrophilic compound
02/27/1990US4904467 Stabilized interleukin-2
02/27/1990CA1266232A1 Method of conferring immuno-tolerance to a specific antigen
02/22/1990WO1990001339A1 Detection and treatment of infectious and inflammatory lesions
02/22/1990WO1990001338A1 Leukocyte adhesion inhibitor
02/22/1990WO1990001326A1 Preparation and use of a physiologically active polypeptide for treating aids
02/22/1990WO1990001271A1 Process for producing antioxidant, biologically active extracts and oily, greasy compositions rich in vitamins and their use as an active ingredient of industrial, therapeutic and cosmetic preparations, as well as an active ingredient added to nutrients and to fodder
02/21/1990EP0354921A1 Compositions and methods of effecting contraception and control of breast cancer.
02/20/1990US4902680 Gonadotrophin, hormones
02/20/1990US4902505 Chimeric peptides for neuropeptide delivery through the blood-brain barrier
02/20/1990US4902501 Pharmaceutical compositions endowed with sequestering activity for the biliary acids, containing colestyramin as their active principle, and process for preparing them
02/15/1990DE3827490A1 Herrichtung und verwendung eines physiologisch aktiven polypeptids zur aids-therapie Fitting and use of a physiologically active polypeptide for AIDS-therapy
02/15/1990DE3826963A1 Pharmaceutical composition for oral administration containing metal complexing agents and metal salts
02/15/1990DE3826962A1 Pharmaceutical composition for oral administration containing non-absorbable metal complexing agents
02/13/1990US4900749 Isoprenoidamine compounds useful as antiulcer agents
02/13/1990US4900735 Beta adrenergic and steroid for animal weight increase
02/13/1990US4900723 In mammals, following surgery
02/13/1990US4900720 Plasmapheresis
02/13/1990CA1265747A1 Anesthetic methods for mammals
02/08/1990WO1990000903A1 Method and compositions for the treatment and prevention of septic shock
02/08/1990WO1990000899A1 Compositions and methods for treating skin conditions and promoting wound healing
02/07/1990EP0353960A2 Polyspecific anti-leukocyte conjugate for detection and treatment of infectious and inflammatory lesions
02/07/1990EP0353262A1 New therapeutical use of h 2?-receptor-blocking compounds
02/07/1990CN1039358A Process for preparing sinergistic composition
02/06/1990US4898857 Treating control nervous system diseases
02/06/1990US4898856 Method for treating central nervous system diseases
01/1990
01/30/1990US4897403 Verapamil and chloroquine
01/30/1990US4897394 Antiviral combinations
01/30/1990US4897389 Using estrogenic hormones
01/30/1990CA1265009A1 Initiating reperfusion treatment when heart attack symptoms are present
01/25/1990WO1990000405A1 Immunoconjugates for cancer diagnosis and therapy
01/25/1990WO1990000400A1 Tumor necrosis enhancing factor and methods of preparation and use
01/24/1990EP0351897A2 Skin penetration system for salts of amine-functional drugs
01/24/1990EP0351767A2 Use of potassium channel activators to inhibit myocardial cell necrosis and to maintain the functioning of the heart during myocardial ischemia and/or reperfusion
01/24/1990EP0351755A1 Combination of a calcium channel blocker and thromboxane A2 receptor antagonist or synthetase inhibitor and method for treating ischemia employing such combination
01/24/1990EP0351698A1 Synergistic pharmaceutical composition with an antimicrobial action and process for preparing same
01/23/1990US4895845 Reserpine and trazodone, bupropion or fluoxetine antidepressant
01/23/1990US4895726 Anticholesterol, antilipemic, micronized with surfactant
01/23/1990CA1264667A1 Process for the preparation of prolonged-action immunotoxins containing a glycopeptide constituent which inactivates ribosomes, modified on its polysaccharide units
01/17/1990EP0351017A2 Pharmaceutical composition useful for the treatment of cardiovascular diseases
01/17/1990EP0350973A1 Means and product for the diagnosis and therapy of tumours and for the treatment of weaknesses of the cellular and humoral immune system
01/16/1990US4894454 Pharmaceutical preparations
01/16/1990US4894443 Polypeptides, antibodies
01/16/1990US4894373 Antiestrogens and their use in treatment of menopause and osteoporosis
01/16/1990US4894225 Combination therapy using antitumor immunotoxins with tumor necrosis factor
01/11/1990WO1990000061A1 Method for the treatment and the diagnosis of coronary heart disease
01/11/1990WO1990000055A1 Method of inhibiting the activity of human immunodeficiency virus (hiv) in vivo
01/10/1990EP0350230A2 Immunoconjugates for cancer diagnosis and therapy
01/10/1990CN1038585A Clear away heart-fire liquid and process for preparing same
01/03/1990EP0349243A2 Antiviral combinations and compounds therefor
01/02/1990US4891356 Proteinase inhibitors for treatment of gastrointestinal ulcer disease
01/02/1990US4891226 Pharmaceutical which can be administered nasally, a process for its preparation, and its use
12/1989
12/28/1989WO1989012463A1 Method and therapeutic compositions for the treatment of myocardial infarction
12/28/1989WO1989012459A1 Mhc-mediated toxic conjugates useful in ameliorating autoimmunity
12/27/1989EP0348290A2 Activated killer monocytes : tumoricidal activity and method of monitoring same
12/27/1989EP0347864A2 Anti-atherogenic agents
12/20/1989EP0347057A1 Method of treating myeloid leukemias
12/20/1989EP0346451A1 Antiviral activity of fatty acids and monoglycerides
12/20/1989EP0346445A1 Dextrorphan potentiator for anticonvulsant composition and method
12/20/1989EP0174342B1 Brain-specific analogues of centrally acting amines
12/19/1989US4888354 Skin penetration enhancement using free base and acid addition salt combinations of active agents
12/19/1989US4888331 Coadministration of antigestagen and antiestrogen for gynecological disorders, abortion and labor induction
12/14/1989WO1989011869A1 Antibody modified with toxin
12/14/1989WO1989011867A1 Protein crosslinking reagents cleavable within acidified intracellular vesicles
12/14/1989WO1989011864A1 Method of treating myeloid leukemias
12/14/1989WO1989011861A1 Derivatives of platinum (p) with polyanion of deoxyribonucleic acid, method for obtaining them and pharmaceutical antitumor preparation based on them
12/14/1989WO1989011860A1 Combinations of soluble t4 proteins and anti-retroviral agents and methods for treating or preventing aids, arc and hiv infection
12/14/1989WO1989011854A1 Pharmacological treatment of ocular development
12/14/1989WO1989011853A1 Use of local anaesthetic agents in the manufacture of preparations with wound healing effect
12/14/1989WO1989011851A1 Treatment of inflammatory diseases, in particular rheumatoid arthritis
12/14/1989WO1989011850A1 Method for making solvent dilution microcarriers
12/13/1989EP0346014A1 Therapeutic product for the treatment of peri- or postmenopausal conditions
12/13/1989EP0345948A2 Use of 5-HT1A agonists for the manufacture of a medicament protecting against ischaemic damage
12/13/1989EP0345931A1 Certain PAF antagonist/antihistamine combinations and methods
12/13/1989EP0345304A1 Pharmaceutical compositions
12/13/1989EP0345302A1 Liposomal vesicles for intraperitoneally administering therapeutic agents
12/12/1989US4886789 Peritoneal dialysis and compositions for use therein
12/06/1989EP0345068A2 Agonist of gamma-aminobutyric acid
12/06/1989EP0344586A2 Medicine containing a TNF inhibitor
12/06/1989EP0344572A2 Composition of angiotensin-converting-enzyme inhibitor with calcium chanell modulators and uses thereof as pharmaceuticals
12/05/1989US4885154 Coadministering a metabolic modulator
11/1989
11/30/1989WO1989011538A1 Platelet-specific chimeric immunoglobulin
11/30/1989WO1989011487A1 Derivatives of cyclic amp as treatment for cancer
11/30/1989WO1989011295A1 Inhibition of lipogenesis
11/30/1989WO1989011287A1 Induction of tolerance to a foreign antigen
11/30/1989WO1989011285A1 Diagnostics and therapy for rheumatoid arthritis
11/30/1989WO1989011274A1 Chemotherapeutic composition for aids
11/30/1989WO1989011269A1 Delayed release formulations
11/29/1989EP0343993A1 Delayed release formulations
11/29/1989EP0343671A2 Pharmaceutical composition for the treatment of skin wounds
11/28/1989US4883803 Treatment of anxiety